Kowal Investment Group LLC Has $437,000 Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Kowal Investment Group LLC increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 32.1% in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 889 shares of the medical equipment provider’s stock after purchasing an additional 216 shares during the quarter. Kowal Investment Group LLC’s holdings in Intuitive Surgical were worth $437,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Mirador Capital Partners LP lifted its stake in shares of Intuitive Surgical by 1.4% in the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock worth $1,732,000 after buying an additional 50 shares during the last quarter. Advisors Asset Management Inc. lifted its position in shares of Intuitive Surgical by 18.1% during the 1st quarter. Advisors Asset Management Inc. now owns 7,380 shares of the medical equipment provider’s stock worth $2,945,000 after purchasing an additional 1,129 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund increased its position in Intuitive Surgical by 617.1% during the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock worth $39,622,000 after acquiring an additional 76,649 shares during the period. Brookstone Capital Management raised its position in shares of Intuitive Surgical by 22.4% during the second quarter. Brookstone Capital Management now owns 12,530 shares of the medical equipment provider’s stock valued at $5,340,000 after buying an additional 2,289 shares during the last quarter. Finally, M&G Plc lifted its stake in shares of Intuitive Surgical by 53.5% in the second quarter. M&G Plc now owns 5,069 shares of the medical equipment provider’s stock valued at $2,256,000 after buying an additional 1,766 shares during the period. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Down 0.4 %

Shares of ISRG stock opened at $476.59 on Thursday. Intuitive Surgical, Inc. has a 12 month low of $254.85 and a 12 month high of $496.48. The firm has a market cap of $169.05 billion, a price-to-earnings ratio of 86.03, a PEG ratio of 5.40 and a beta of 1.39. The stock has a 50-day moving average price of $482.49 and a 200 day moving average price of $436.65.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.78 EPS for the quarter, topping analysts’ consensus estimates of $1.54 by $0.24. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The business had revenue of $2.01 billion during the quarter, compared to analysts’ expectations of $1.97 billion. During the same period in the previous year, the firm earned $1.18 earnings per share. The firm’s quarterly revenue was up 14.5% compared to the same quarter last year. Sell-side analysts predict that Intuitive Surgical, Inc. will post 5.22 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, EVP Robert Desantis sold 1,413 shares of Intuitive Surgical stock in a transaction on Friday, July 26th. The shares were sold at an average price of $438.60, for a total transaction of $619,741.80. Following the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,414,931.60. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other news, Director Amy L. Ladd sold 450 shares of the firm’s stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $490.28, for a total transaction of $220,626.00. Following the sale, the director now owns 821 shares of the company’s stock, valued at $402,519.88. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Robert Desantis sold 1,413 shares of the business’s stock in a transaction that occurred on Friday, July 26th. The shares were sold at an average price of $438.60, for a total value of $619,741.80. Following the completion of the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,414,931.60. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 53,120 shares of company stock worth $25,528,753. Insiders own 0.90% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the company. Morgan Stanley boosted their price target on Intuitive Surgical from $375.00 to $460.00 and gave the company an “equal weight” rating in a research note on Monday, July 15th. Royal Bank of Canada raised their target price on Intuitive Surgical from $515.00 to $525.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 8th. Piper Sandler boosted their price target on shares of Intuitive Surgical from $490.00 to $495.00 and gave the company an “overweight” rating in a report on Friday, July 19th. Stifel Nicolaus raised their price objective on shares of Intuitive Surgical from $430.00 to $475.00 and gave the stock a “buy” rating in a report on Friday, July 19th. Finally, BTIG Research upped their target price on shares of Intuitive Surgical from $494.00 to $518.00 and gave the company a “buy” rating in a research note on Monday. Six research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus price target of $474.16.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.